Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

BGMS vs LWAY

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BGMS
Bio Green Med Solution, Inc.

Medical - Pharmaceuticals

HealthcareNASDAQ • US
Market Cap$22K
5Y Perf.-30.4%
LWAY
Lifeway Foods, Inc.

Packaged Foods

Consumer DefensiveNASDAQ • US
Market Cap$391M
5Y Perf.+39.4%

BGMS vs LWAY — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BGMS logoBGMS
LWAY logoLWAY
IndustryMedical - PharmaceuticalsPackaged Foods
Market Cap$22K$391M
Revenue (TTM)$81K$212M
Net Income (TTM)$-5M$14M
Gross Margin18.5%27.4%
Operating Margin-113.2%7.6%
Forward P/E20.7x
Total Debt$0.00$360K
Cash & Equiv.$3M$6M

Quick Verdict: BGMS vs LWAY

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LWAY leads in 5 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
BGMS
Bio Green Med Solution, Inc.
The Specific-Use Pick

In this particular matchup, BGMS is outpaced on most metrics by others in the set.

Best for: healthcare exposure
LWAY
Lifeway Foods, Inc.
The Income Pick

LWAY carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 2 yrs, beta 0.72
  • Rev growth 13.7%, EPS growth 50.8%, 3Y rev CAGR 14.5%
  • 167.1% 10Y total return vs BGMS's -83.6%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthLWAY logoLWAY13.7% revenue growth vs BGMS's -89.8%
Quality / MarginsLWAY logoLWAY6.5% margin vs BGMS's -67.1%
Stability / SafetyLWAY logoLWAYBeta 0.72 vs BGMS's 2.04
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)LWAY logoLWAY+6.1% vs BGMS's -83.6%
Efficiency (ROA)LWAY logoLWAY13.6% ROA vs BGMS's -106.7%

BGMS vs LWAY — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLWAYLAGGINGBGMS

Income & Cash Flow (Last 12 Months)

LWAY leads this category, winning 5 of 6 comparable metrics.

LWAY is the larger business by revenue, generating $212M annually — 2623.4x BGMS's $81,000. LWAY is the more profitable business, keeping 6.5% of every revenue dollar as net income compared to BGMS's -67.1%. On growth, BGMS holds the edge at +7.1% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBGMS logoBGMSBio Green Med Sol…LWAY logoLWAYLifeway Foods, In…
RevenueTrailing 12 months$81,000$212M
EBITDAEarnings before interest/tax-$9M$20M
Net IncomeAfter-tax profit-$5M$14M
Free Cash FlowCash after capex-$6M$0
Gross MarginGross profit ÷ Revenue+18.5%+27.4%
Operating MarginEBIT ÷ Revenue-113.2%+7.6%
Net MarginNet income ÷ Revenue-67.1%+6.5%
FCF MarginFCF ÷ Revenue-75.2%-7.8%
Rev. Growth (YoY)Latest quarter vs prior year+7.1%+18.0%
EPS Growth (YoY)Latest quarter vs prior year+99.4%+15.8%
LWAY leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

BGMS leads this category, winning 2 of 2 comparable metrics.
MetricBGMS logoBGMSBio Green Med Sol…LWAY logoLWAYLifeway Foods, In…
Market CapShares × price$21,990$391M
Enterprise ValueMkt cap + debt − cash-$3M$385M
Trailing P/EPrice ÷ TTM EPS-0.00x28.81x
Forward P/EPrice ÷ next-FY EPS est.20.68x
PEG RatioP/E ÷ EPS growth rate0.86x
EV / EBITDAEnterprise value multiple19.12x
Price / SalesMarket cap ÷ Revenue0.51x1.84x
Price / BookPrice ÷ Book value/share4.64x
Price / FCFMarket cap ÷ FCF
BGMS leads this category, winning 2 of 2 comparable metrics.

Profitability & Efficiency

LWAY leads this category, winning 4 of 5 comparable metrics.

LWAY delivers a 17.2% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $-187 for BGMS. On the Piotroski fundamental quality scale (0–9), LWAY scores 4/9 vs BGMS's 1/9, reflecting mixed financial health.

MetricBGMS logoBGMSBio Green Med Sol…LWAY logoLWAYLifeway Foods, In…
ROE (TTM)Return on equity-187.3%+17.2%
ROA (TTM)Return on assets-106.7%+13.6%
ROICReturn on invested capital+17.8%
ROCEReturn on capital employed+19.7%
Piotroski ScoreFundamental quality 0–914
Debt / EquityFinancial leverage0.00x
Net DebtTotal debt minus cash-$3M-$5M
Cash & Equiv.Liquid assets$3M$6M
Total DebtShort + long-term debt$0$360,000
Interest CoverageEBIT ÷ Interest expense256.99x
LWAY leads this category, winning 4 of 5 comparable metrics.

Total Returns (Dividends Reinvested)

LWAY leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in LWAY five years ago would be worth $52,703 today (with dividends reinvested), compared to $1,637 for BGMS. Over the past 12 months, LWAY leads with a +6.1% total return vs BGMS's -83.6%. The 3-year compound annual growth rate (CAGR) favors LWAY at 62.3% vs BGMS's -45.3% — a key indicator of consistent wealth creation.

MetricBGMS logoBGMSBio Green Med Sol…LWAY logoLWAYLifeway Foods, In…
YTD ReturnYear-to-date-30.1%+12.5%
1-Year ReturnPast 12 months-83.6%+6.1%
3-Year ReturnCumulative with dividends-83.6%+327.3%
5-Year ReturnCumulative with dividends-83.6%+427.0%
10-Year ReturnCumulative with dividends-83.6%+167.1%
CAGR (3Y)Annualised 3-year return-45.3%+62.3%
LWAY leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

LWAY leads this category, winning 2 of 2 comparable metrics.

LWAY is the less volatile stock with a 0.72 beta — it tends to amplify market swings less than BGMS's 2.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LWAY currently trades 75.0% from its 52-week high vs BGMS's 14.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBGMS logoBGMSBio Green Med Sol…LWAY logoLWAYLifeway Foods, In…
Beta (5Y)Sensitivity to S&P 5002.04x0.72x
52-Week HighHighest price in past year$6.70$34.20
52-Week LowLowest price in past year$0.73$17.31
% of 52W HighCurrent price vs 52-week peak+14.7%+75.0%
RSI (14)Momentum oscillator 0–10048.364.8
Avg Volume (50D)Average daily shares traded97K63K
LWAY leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

LWAY leads this category, winning 1 of 1 comparable metric.
MetricBGMS logoBGMSBio Green Med Sol…LWAY logoLWAYLifeway Foods, In…
Analyst RatingConsensus buy/hold/sellBuy
Price TargetConsensus 12-month target$35.00
# AnalystsCovering analysts6
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises02
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
LWAY leads this category, winning 1 of 1 comparable metric.
Key Takeaway

LWAY leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BGMS leads in 1 (Valuation Metrics).

Best OverallLifeway Foods, Inc. (LWAY)Leads 5 of 6 categories
Loading custom metrics...

BGMS vs LWAY: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is BGMS or LWAY a better buy right now?

For growth investors, Lifeway Foods, Inc.

(LWAY) is the stronger pick with 13. 7% revenue growth year-over-year, versus -89. 8% for Bio Green Med Solution, Inc. (BGMS). Lifeway Foods, Inc. (LWAY) offers the better valuation at 28. 8x trailing P/E (20. 7x forward), making it the more compelling value choice. Analysts rate Lifeway Foods, Inc. (LWAY) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — BGMS or LWAY?

Over the past 5 years, Lifeway Foods, Inc.

(LWAY) delivered a total return of +427. 0%, compared to -83. 6% for Bio Green Med Solution, Inc. (BGMS). Over 10 years, the gap is even starker: LWAY returned +167. 1% versus BGMS's -83. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — BGMS or LWAY?

By beta (market sensitivity over 5 years), Lifeway Foods, Inc.

(LWAY) is the lower-risk stock at 0. 72β versus Bio Green Med Solution, Inc. 's 2. 04β — meaning BGMS is approximately 183% more volatile than LWAY relative to the S&P 500.

04

Which is growing faster — BGMS or LWAY?

By revenue growth (latest reported year), Lifeway Foods, Inc.

(LWAY) is pulling ahead at 13. 7% versus -89. 8% for Bio Green Med Solution, Inc. (BGMS). On earnings-per-share growth, the picture is similar: Bio Green Med Solution, Inc. grew EPS 92. 2% year-over-year, compared to 50. 8% for Lifeway Foods, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — BGMS or LWAY?

Lifeway Foods, Inc.

(LWAY) is the more profitable company, earning 6. 5% net margin versus -260. 7% for Bio Green Med Solution, Inc. — meaning it keeps 6. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LWAY leads at 7. 6% versus -279. 2% for BGMS. At the gross margin level — before operating expenses — BGMS leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — BGMS or LWAY?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is BGMS or LWAY better for a retirement portfolio?

For long-horizon retirement investors, Lifeway Foods, Inc.

(LWAY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), +167. 1% 10Y return). Bio Green Med Solution, Inc. (BGMS) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LWAY: +167. 1%, BGMS: -83. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between BGMS and LWAY?

These companies operate in different sectors (BGMS (Healthcare) and LWAY (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

BGMS

High-Growth Disruptor

  • Sector: Healthcare
  • Market Cap > $2B
  • Revenue Growth > 355%
Run This Screen
Stocks Like

LWAY

High-Growth Disruptor

  • Sector: Consumer Defensive
  • Market Cap > $100B
  • Revenue Growth > 8%
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BGMS and LWAY on the metrics below

Revenue Growth>
%
(BGMS: 710.0% · LWAY: 18.0%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.